{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:12:52Z","timestamp":1785683572364,"version":"3.56.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.hoc.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:17:53Z","timestamp":1543263473000},"page":"149-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cutaneous B-Cell Lymphoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Amrita","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joi B.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.hoc.2018.08.006_bib2","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2018.08.006_bib3","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"issue":"20","key":"10.1016\/j.hoc.2018.08.006_bib4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2018.08.006_bib5","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"214","article-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.hoc.2018.08.006_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: Clinical and theraputic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2018.08.006_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.critrevonc.2009.09.003","article-title":"Primary cutaneous marginal zone lymphoma","volume":"74","author":"Dalle","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.006_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/bjd.14932","article-title":"Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?","volume":"176","author":"Amitay-Laish","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.hoc.2018.08.006_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","article-title":"Clinical and Laboratory Investigations Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases","volume":"147","author":"Servitje","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000478-199901000-00010","article-title":"Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features","volume":"23","author":"Baldassano","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.08.006_bib12","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.006_bib13","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.006_bib14","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1600-0463.2007.00797.x","article-title":"Primary cutaneous CD5+ marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman\u2019s disease","volume":"115","author":"Tsukamoto","year":"2007","journal-title":"APMIS"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.006_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DAD.0b013e318267495f","article-title":"Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature","volume":"35","author":"Magro","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.hoc.2018.08.006_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/DAD.0000000000000022","article-title":"Clonality assessment of cutaneous B-cell lymphoid proliferations: a comparison of flow cytometry immunophenotyping, molecular studies, and immunohistochemistry\/in situ hybridization and review of the literature","volume":"36","author":"Schafernak","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.hoc.2018.08.006_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1309\/AJCPW64FFBTTPKFN","article-title":"Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T\u00a0cell-rich background","volume":"133","author":"Geyer","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2018.08.006_bib18","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamadermatol.2013.9223","article-title":"High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas","volume":"150","author":"Guitart","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.hoc.2018.08.006_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2008.04.012","article-title":"Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome in primary cutaneous marginal zone lymphoma","volume":"59","author":"Gerami","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13000-016-0588-x","article-title":"Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report","volume":"11","author":"Hatem","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.hoc.2018.08.006_bib22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.08.006_bib23","series-title":"WHO Classification of tumors of haematopoietic and lymphoid tissues","first-page":"227","article-title":"Primary cutaneous follicle centre lymphoma","author":"Willemze","year":"2008"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","author":"Hamilton","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.006_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1309\/AJCPNLC9NC9WTQYY","article-title":"Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Swerdlow","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.006_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2010.06.059","article-title":"Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment","volume":"65","author":"Gulia","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.006_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":"Subcutaneous, Blastic Natural Killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2018.08.006_bib29","first-page":"9549428","article-title":"Primary cutaneous follicle centre lymphoma with hodgkin and reed-sternberg like cells: a case report and review of the literature","volume":"2017","author":"Aldarweesh","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.dad.0000245205.52139.c1","article-title":"Cutaneous sarcomatoid B-cell lymphoma","volume":"29","author":"Ries","year":"2007","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000372-200008000-00001","article-title":"Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma","volume":"22","author":"Cerroni","year":"2000","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.006_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0000000000000388","article-title":"Cutaneous spindle-cell B-cell Lymphomas: most are neoplasms of follicular center cell origin","volume":"39","author":"Charli-Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/his.13279","article-title":"Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas","volume":"71","author":"Verdanet","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0000000000000567","article-title":"Primary cutaneous follicle center lymphomas expressing BCL2 protein frequently harbor BCL2 gene break and may present 1p36 deletion: a study of 20 cases","volume":"40","author":"Szablewski","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.hoc.2018.08.006_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/his.12855","article-title":"Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform","volume":"69","author":"Robson","year":"2016","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.006_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/DAD.0000000000000009","article-title":"Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases","volume":"36","author":"Plaza","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.hoc.2018.08.006_bib38","unstructured":"NCCN Guidelines for Primary Cutaneous B-cell Lymphomas. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pcbcl.pdf. Accessed May 28, 2018."},{"issue":"2","key":"10.1016\/j.hoc.2018.08.006_bib39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaad.2017.07.053","article-title":"Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: a retrospective study","volume":"78","author":"Goyal","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.hoc.2018.08.006_bib40","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"242","article-title":"Primary cutaneous DLBCL, leg type","author":"Meijer","year":"2008"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.006_bib41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/hupa.2002.126881","article-title":"Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity","volume":"33","author":"Paulli","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2018.08.006_bib42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphoma of the leg","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.006_bib43","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.hoc.2018.08.006_bib44","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.006_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.hoc.2018.08.006_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-018-0041-7","article-title":"Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas","author":"Menguy","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.006_bib47","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.006_bib48","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.006_bib49","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.006_bib50","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1524-4725.1984.tb00898.x","article-title":"Skin involvement in malignant B-cell lymphomas","volume":"10","author":"Sterry","year":"1984","journal-title":"J\u00a0Dermatol Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2011.03.031","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features","volume":"66","author":"Muniesa","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.006_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/S0190-9622(03)00889-2","article-title":"Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a north american series","volume":"49","author":"Brogan","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.006_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archdermatol.2009.23","article-title":"Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab","volume":"145","author":"Grange","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.006_bib56","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.hoc.2018.08.006_bib57","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1200\/JCO.2007.13.6929","article-title":"Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014","volume":"26","author":"Persky","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.006_bib58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.006_bib59","first-page":"393","article-title":"Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy","volume":"19","author":"Posada-Garcia","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.hoc.2018.08.006_bib60","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"252","article-title":"Intravascular large B-cell lymphoma","author":"Nakamura","year":"2008"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.006_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u201ccutaneous variant\u201d","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.006_bib62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5858\/arpa.2010-0747-RS","article-title":"Intravascular large B-cell lymphoma","volume":"136","author":"Orwat","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"21","key":"10.1016\/j.hoc.2018.08.006_bib63","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":"Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting","volume":"25","author":"Ponzoni","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.006_bib64","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1470-2045(09)70140-8","article-title":"Presentation and management of intravascular large B-cell lymphoma","volume":"10","author":"Shimada","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.006_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2018.08.006_bib66","doi-asserted-by":"crossref","first-page":"9413015","DOI":"10.1155\/2018\/9413015","article-title":"Small cell variant of intravascular large B-cell lymphoma: highlighting a potentially fatal and easily missed diagnosis","volume":"2018","author":"Rahmani","year":"2018","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.006_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.11622\/smedj.2018030","article-title":"Intravascular large B-cell lymphoma presenting as panniculitis clinically: a case report","volume":"59","author":"Phoon","year":"2018","journal-title":"Singapore Med J"},{"issue":"18","key":"10.1016\/j.hoc.2018.08.006_bib68","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood-2017-12-822817","article-title":"High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma","volume":"131","author":"Schrader","year":"2018","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:11:47Z","timestamp":1760184707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818307846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0889858818307846"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.08.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous B-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}